Funding/Avalon Ventures

Carolus Therapeutics was founded in 2008 and is privately held.The company raised capital from Avalon Ventures, one of the longest-standing capital firms in San Diego, which has been investing in Life Science and Information Technology opportunities since 1983. Avalon has supported the development of more than 60 early-stage companies, including Athena Neurosciences (acquired by Elan), Onyx Pharmaceuticals, Sequana Therapeutics (acquired by Celera Genomics), Vertex Pharmaceuticals, Synaptics, Inc., Vocera Communications, Sytera Inc. (acquired by Sirion), Aurora Biosciences, Landmark Graphics, NeoRx, Onyx Pharmaceuticals, and X-Ceptor (acquired by Excelixis). The collective market capitalization of Avalon Ventures’ portfolio companies currently exceeds $11 billion.
[Avalon Ventures Web site]